COVID-19: The situation in Peru and managing radiotherapy patients

Novel treatment strategies for prostate cancer: Senescence, senolytics and myeloid derived suppressor cells

Revolutionising imaging with PSMA PET in prostate cancer

Micro-ultrasound for detection of clinically significant prostate cancer

Shorter hormone therapy for prostate cancer

Over-diagnosis of low-grade prostate cancer, good or bad?

Follow up from MRI imaging for low-grade prostate cancer

PRIAS: Active surveillance for men with low risk prostate cancer

Updates in imaging for oligometastatic disease in urological cancers

EV-103: Enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma

KEYNOTE 199 cohorts 4 & 5: Enzalutamide and pembrolizumab for mCRPC

BCG dosing for bladder cancer: Standard frequency schedule correct